Original Research

Published on 01 Jun 2022

Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator

in Thoracic Oncology

Xinyan Li
Yixiao Yuan
Mintu Pal
Xiulin Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.929655

2,656 views
3 citations

Original Research

Published on 01 Jun 2022

Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers

in Thoracic Oncology

Chunliu Meng
Fang Wang
Minghong Chen
Hongyun Shi
Lujun Zhao
Ping Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.858634

1,561 views
2 citations

Original Research

Published on 31 May 2022

Perioperative Outcomes of Video-Assisted Thoracoscopic Surgery Versus Open Thoracotomy After Neoadjuvant Chemoimmunotherapy in Resectable NSCLC

in Thoracic Oncology

Baihua Zhang
Qin Xiao
Haifan Xiao
Jie Wu
Desong Yang
Jinming Tang
Xu Li
Zhining Wu
Yong Zhou
Wenxiang Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.858189

3,106 views
17 citations

Original Research

Published on 31 May 2022

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer

in Thoracic Oncology

Isabella Fornacon-Wood
Clara Chan
Neil Bayman
Kathryn Banfill
Joanna Coote
Alex Garbett
Margaret Harris
Andrew Hudson
Jason Kennedy
Laura Pemberton

Frontiers in Oncology

doi 10.3389/fonc.2022.835844

2,388 views
6 citations

Original Research

Published on 31 May 2022

A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients

in Thoracic Oncology

Guangyao Bao
Xiaojiao Guan
Jie Liang
Yao Yao
Yifan Xiang
Tian Li
Xinwen Zhong

Frontiers in Oncology

doi 10.3389/fonc.2022.855305

2,960 views
1 citation

Original Research

Published on 30 May 2022

Combined Radiomic and Visual Assessment for Improved Detection of Lung Adenocarcinoma Invasiveness on Computed Tomography Scans: A Multi-Institutional Study

in Thoracic Oncology

Pranjal Vaidya
Kaustav Bera
Philip A. Linden
Amit Gupta
Prabhakar Shantha Rajiah
David R. Jones
Matthew Bott
Harvey Pass
Robert Gilkeson
Frank Jacono

Frontiers in Oncology

doi 10.3389/fonc.2022.902056

3,954 views
4 citations

Original Research

Published on 30 May 2022

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study

in Thoracic Oncology

Xinyan Li
Xi Chen
Yixiao Yuan
RuiQing Zhai
William C. Cho
Xiulin Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.916947

2,020 views
4 citations

Original Research

Published on 30 May 2022

Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung Adenocarcinoma

in Thoracic Oncology

Guangyao Bao
Tian Li
Xiaojiao Guan
Yao Yao
Jie Liang
Yifang Xiang
Xinwen Zhong

Frontiers in Oncology

doi 10.3389/fonc.2022.882292

1,791 views
9 citations

Mini Review

Published on 27 May 2022

Lung Cancer Treatment: From Tradition to Innovation

in Thoracic Oncology

Giuseppe Mangiameli
Ugo Cioffi
Alberto Testori

Frontiers in Oncology

doi 10.3389/fonc.2022.858242

3,569 views
16 citations

Case Report

Published on 26 May 2022

Long-Term Clinical Benefit in EGFR-Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report

in Thoracic Oncology

Junru Ye
Yutong Ma
Qiuxiang Ou
Junrong Yan
Bin Ye
Yuping Li

Frontiers in Oncology

doi 10.3389/fonc.2022.883367

3,083 views
3 citations

Original Research

Published on 24 May 2022

Combining a CDK4/6 Inhibitor With Pemetrexed Inhibits Cell Proliferation and Metastasis in Human Lung Adenocarcinoma

in Thoracic Oncology

Yuan Ke
Cheng-Gong Liao
Zheng-Qing Zhao
Xiao-Min Li
Rong-Jie Lin
Long Yang
He-Long Zhang
Ling-Min Kong

Frontiers in Oncology

doi 10.3389/fonc.2022.880153

3,082 views
7 citations

Original Research

Published on 24 May 2022

The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective Research

in Thoracic Oncology

Yan Meng
Yilin Yang
Yujia Fang
Xinqing Lin
Xiaohong Xie
Haiyi Deng
Jianhui Wu
Maolin Zhou
Ni Sun
Zhanhong Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.864367

3,670 views
9 citations

Case Report

Published on 23 May 2022

Multiple Primary Lung Cancers With ALK Rearrangement: A Case Report and Literature Review

in Thoracic Oncology

Zhou Huimin
Wang Xueting
Qi Qi
Feng Lingxin
Yang Xue
Yu Zhuang
Wang Jing

Frontiers in Oncology

doi 10.3389/fonc.2022.897451

2,552 views
2 citations

Original Research

Published on 23 May 2022

Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III Non-Small-Cell Lung Cancer: Results of KINDLE-Vietnam Cohort

in Thoracic Oncology

Tu Van Dao
Tuan Bao Diep
Tri Le Phuong
Reto Huggenberger
Amit Kumar

Frontiers in Oncology

doi 10.3389/fonc.2022.842296

3,777 views
2 citations

Original Research

Published on 23 May 2022

Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma

in Thoracic Oncology

Ting Xu
Zhe Zhang
Hongqiang Chen
Ruili Cai
Qian Yang
Qi Liu
Yahan Fan
Wenbin Liu
Chunyan Yao

Frontiers in Oncology

doi 10.3389/fonc.2022.843325

2,657 views
2 citations

Original Research

Published on 20 May 2022

Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma

in Thoracic Oncology

Szu-Chun Yang
Chien-Chung Lin
Yi-Lin Chen
Wu-Chou Su

Frontiers in Oncology

doi 10.3389/fonc.2022.873111

3,572 views
5 citations

Navigation group

Articles

Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator

Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers

Perioperative Outcomes of Video-Assisted Thoracoscopic Surgery Versus Open Thoracotomy After Neoadjuvant Chemoimmunotherapy in Resectable NSCLC

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer

A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients

Combined Radiomic and Visual Assessment for Improved Detection of Lung Adenocarcinoma Invasiveness on Computed Tomography Scans: A Multi-Institutional Study

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study

Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung Adenocarcinoma

Lung Cancer Treatment: From Tradition to Innovation

Long-Term Clinical Benefit in EGFR-Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report

Combining a CDK4/6 Inhibitor With Pemetrexed Inhibits Cell Proliferation and Metastasis in Human Lung Adenocarcinoma

The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective Research

Multiple Primary Lung Cancers With ALK Rearrangement: A Case Report and Literature Review

Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III Non-Small-Cell Lung Cancer: Results of KINDLE-Vietnam Cohort

Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma

Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma